School of Medicine


Showing 1-8 of 8 Results

  • Michele Calos

    Michele Calos

    Professor of Genetics, Emerita

    Current Research and Scholarly InterestsMy lab is developing innovative gene and stem cell therapies for genetic diseases, with a focus on gene therapy and regenerative medicine.

    We have created novel methods for inserting therapeutic genes into the chromosomes at specific places by using homologous recombination and recombinase enzymes.

    We are working on 3 forms of muscular dystrophy.

    We created induced pluripotent stem cells from patient fibroblasts, added therapeutic genes, differentiated, and engrafted the cells.

  • MaryAnn Campion

    MaryAnn Campion

    Professor (Teaching) of Genetics

    Current Research and Scholarly InterestsMy primary research interests include 1) genetics education, 2) genetic counseling access, service delivery, and psychosocial assessment, 3) professional development, faculty vitality, and burnout.

  • Howard Y. Chang, MD, PhD

    Howard Y. Chang, MD, PhD

    Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
    On Leave from 12/16/2024 To 12/15/2026

    Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.

  • Mike Cherry

    Mike Cherry

    Professor (Research) of Genetics, Emeritus

    Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.

  • Stanley N. Cohen, MD

    Stanley N. Cohen, MD

    Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
    On Partial Leave from 06/04/2025 To 07/16/2025

    Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.

  • Le Cong

    Le Cong

    Assistant Professor of Pathology (Pathology Research) and of Genetics

    Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene&cell therapy. We also leverages these gene-editing tools for single-cell functional screening, to probe molecular mechanisms of cancer and immunological diseases. To accelerate our work, we integrate AI and machine learning to design and evolve gene-editing proteins/RNAs in silico, pushing the frontier that bridges computational and experimental biology.

  • David Cox

    David Cox

    Assistant Professor of Genetics

    BioDavid Cox is an Assistant Professor of Genetics and by courtesy of Medicine (Hematology) at Stanford University and Principal Investigator of the Cox Lab (coxlab.bio), which is opening in July 2025. He is also a ChEM-H Institute Scholar and Chan Zuckerberg Biohub Investigator.

    He completed his undergraduate studies in biology at Stanford University, where he worked with Irving Weissman on understanding how the innate immune system recognizes cancer cells. He then entered the Harvard-MIT MD-PhD program, earning his MD from the Harvard-MIT program in Health Sciences and Technology (HST) and his PhD in biology from MIT. His doctoral dissertation with Feng Zhang focused on the discovery and development of CRISPR-Cas enzymes as novel DNA and RNA editing tools. During his final year of medical school, he worked as a visiting scientist with David Baker, where he initiated efforts to design sequence-specific DNA binding proteins de novo.

    Following medical school, Cox completed internal medicine residency and a clinical fellowship in hematology at Stanford, where he concurrently conducted postdoctoral research in Rhiju Das's lab. In the Das lab, he fine-tuned large language models for RNA structure prediction and developed new methods for highly multiplexed detection of RNA-protein interactions.

    His current list of publications and patents is available here: https://scholar.google.com/citations?user=ZohHoFYAAAAJ&hl=en&oi=ao

  • Christina Curtis

    Christina Curtis

    RZ Cao Professor, Professor of Genetics and of Biomedical Data Science

    Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.